BASF, DE000BASF111

BASF confirms Evonik talks as BASF stock sits 9.06 percent below its high

Published on 10/05/2026 at 12:57 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Second-quarter revenue reached EUR 17.2 billion. BASF stock costs EUR 50.06 versus EUR 50.13 on October 5, 2026, minus 0.14 percent.

Schwarz-Weiß-Reportageporträt einer Laborantin, die ein Reagenzglas gegen das Licht hält
Hochkontrast-Schwarzweiß-Reportagefoto einer Laborantin mit Sicherheitsbrille und Laborkittel, die ein Reagenzglas mit klarer Flüssigkeit gegen diffuses Fensterlicht hält. Entscheidungsmoment-Komposition im Leica-M-Stil, starke Schatten, ausgeprägte Filmkörnung. Hintergrund zeigt verschwommen Laborgeräte aus Glas, Illustration mit AI erstellt.

BASF stock was trading at EUR 50.06 at Lang & Schwarz on October 5, 2026 at 12:49 p.m. CEST, 9.06 percent below the 52-week high of EUR 55.05. On September 25, 2026, BASF confirmed exploratory talks with Evonik and RAG-Stiftung about a potential takeover.

Evonik talks remain exploratory

BASF said the course and outcome of the discussions remained open, while describing acquisitions that strengthen its core businesses and support profitable growth as part of its strategy. The statement therefore establishes a corporate catalyst, but it does not set transaction terms or a timetable.

The scale of the proposal is central to the debate. Deutsche Bank Research kept a Buy rating and a EUR 60.00 price target on September 28, 2026, according to FinanzNachrichten. The report said a EUR 25.00 offer per Evonik share would equal about 35 percent of BASF's own market value.

Quarterly figures support the strategy

For the second quarter of 2026, BASF revenue rose by EUR 2.4 billion to EUR 17.2 billion, according to Finanztrends. Adjusted EBITDA increased by EUR 854.0 million to EUR 2.4 billion, and BASF raised its adjusted EBITDA outlook for fiscal year 2026 to EUR 6.9 billion to EUR 7.7 billion.

JPMorgan retained an Underweight rating and a EUR 40.00 price target on September 28, 2026, FinanzNachrichten reported. JPMorgan identified overlapping businesses with Evonik across about one-third of BASF revenue, while seeing lower overlap in operating profit.

BASF stock stays below its yearly high

The market capitalization stood at EUR 43.2 billion as of October 5, 2026. The Lang & Schwarz quote was EUR 50.06, down EUR 0.07 from the prior close of EUR 50.13 on October 2, 2026, a change of minus 0.14 percent.

The primary listing is on Xetra, where BASF trades under BAS. The next scheduled quarterly information is due on October 28, 2026, when BASF plans to publish its third-quarter statement and related materials.

The further course of trading is shown by the continuously updated real-time quote of BASF stock.

BASF stock facts

  • Company: BASF SE
  • ISIN: DE000BASF111
  • WKN: BASF11
  • Ticker: BAS
  • Primary exchange: Xetra
  • Price Lang & Schwarz as of October 5, 2026, 12:49 p.m. CEST: EUR 50.06
  • Change versus prior close: minus 0.14 percent
  • Prior close Lang & Schwarz October 2, 2026: EUR 50.13
  • Market capitalization: EUR 43.2 billion (as of October 5, 2026)
  • 52-week range: EUR 41.48-55.05 (as of October 5, 2026)
  • Sector / Industry: Materials / Chemicals
  • Index membership: DAX
  • Next earnings date: October 28, 2026

More news and analyses on BASF stock

Disclaimer...

en | DE000BASF111 | BASF | boerse | 70232446 | bgmi